7May2015 Gates Foundation VC Portfolio: Where is the Global Health Investment Going? /Luke Timmerman/6/All, Diagnostics, Strategy07 May 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.